Brief: Cumberland Pharmaceuticals Q3 revenue USD 10.1 million.
07/11/2023 23:40
Nov 7 (Reuters) - Cumberland Pharmaceuticals Q3 revenue USD 10.1 million. * Q3 adjusted net income USD 260.146 THOUSAND * Q3 operating expenses USD 12 million * Q3 net income USD -1 million
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM